vimarsana.com
Home
Live Updates
Inozyme Pharma Highlights Inclusion of Generalized Arterial
Inozyme Pharma Highlights Inclusion of Generalized Arterial
Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England's Generation Study of Rare Conditions -October 10, 2023 at 08:31 am EDT
BOSTON, Oct. 10, 2023 -- Inozyme Pharma, Inc. , a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal...
Related Keywords
United Kingdom ,
Boston ,
Massachusetts ,
United States ,
Inozyme Pharma ,
Catherine Nester ,
Stefan Riley ,
Matt Pera ,
Facebook ,
Exchange Commission ,
United Kingdom National Health Service ,
Twitter ,
Linkedin ,
Corporate Communications ,
Inozyme Pharma Inc ,
Globenewswire Inc ,
Nasdaq ,
Generalized Arterial Calcification ,
Genomic England ,
National Health Service ,
Genomics England ,
Generation Study ,
Private Securities Litigation Reform Act ,
Annual Report ,
Markets ,